Stocks
Single names, sectors, valuations and the trades behind the tape, explained in plain language.
Boston Scientific's cyberattack muddies recovery timeline, Truist warns
Boston Scientific shares dropped nearly 6% after Truist Securities said a recent cyberattack makes the recovery timeline uncertain and could
Novartis trial miss hits biotech stocks, Amgen falls 9%
Novartis plunged 14% after its phase 3 Harbor trial missed its primary endpoint, sending ripples through biotech stocks. Amgen fell 9%, whil
CVC explores sale of Dr. Teal's owner Arthea in deal that could value it at $2 billion
CVC Capital Partners is exploring a sale of Arthea, the personal care company behind Dr. Teal's, in a process that could value the business
Robinhood lands first IPO underwriting role on Oura's listing
Smart-ring maker Oura is going public, and Robinhood is on the underwriting team for the first time. The move could give everyday investors
Investindustrial explores sale of bottle-cap maker Guala Closures
Investindustrial has tapped JPMorgan and Mediobanca to weigh a sale of Guala Closures, an Italian maker of bottle caps. The company generate
Target Hospitality wins data center housing deal; analysts raise forecasts
Target Hospitality's new data center housing contract has prompted Oppenheimer to raise its 2026-2027 EBITDA forecasts. The company's pipeli
Colgate's US toothpaste slump may bottom out by early 2027
RBC Capital Markets says Colgate's US toothpaste decline could level off by Q1 2027 as the company moves past self-inflicted missteps. Inter
Electrum boosts Carlin Gold stake to 40% with CA$30M raise
Carlin Gold is raising about CA$30 million for Nevada exploration, with Electrum Gold Exploration buying 16.5 million units to lift its full
Morgan Stanley cuts Peloton to underweight, sees subscriber slide
Morgan Stanley downgraded Peloton, predicting its connected-fitness subscriptions will shrink about 6% a year through fiscal 2029 as more pe
Solidcore's $1.2B buyback signals pause on payouts until 2029
Solidcore Resources is spending $1.2 billion to buy back up to 23.2% of its shares at $11.66 each. The move offers an exit to investors but
Holtec targets $10.2B valuation in fall IPO rush as nuclear deal flow picks up
Holtec, a nuclear technology company, is seeking up to $900 million in an IPO that could value it at $10.2 billion. The listing on Nasdaq an
BofA raises ABB revenue forecasts on data center and grid demand
Bank of America raised its 2027-28 revenue forecasts for ABB's Electrification business, citing strong data center and power grid orders. Th